Dépistage du cancer du sein en Suisse : organisé, opportuniste ou abstention ?

In Switzerland, breast cancer screening takes the form of organised programmes or opportunistic screening. Current programmes cover fifteen out of twenty-six cantons, offer a standardised framework and strict quality control with periodic evaluations. Opportunistic screening broadens access but without systematic quality control, data or equity of access. In both cases, screening leads to earlier detection and reduced mortality of breast cancer but exposes patients to the risks of false positives and overdiagnosis. Abstaining from screening increases the risk of late diagnosis and heavy treatment. An interprofessional approach involving primary care physicians, specialists and public health actors is essential to inform women and offer them high-quality screening that is better integrated into their care pathway.

Authors

Institutions

Publication Details

Journal
Revue Médicale Suisse
Published
2025-01-01
DOI
https://doi.org/10.53738/revmed.2025.21.937.48002
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dépistage du cancer du sein en Suisse : organisé, opportuniste ou abstention ?

Patrice Mathevet, Rami Hajri, Jean‐Luc Bulliard, Khalil Zaman et al.
Revue Médicale Suisse
Global Cancer Incidence and Screening
article

Dépistage du cancer du sein en Suisse : organisé, opportuniste ou abstention ?

Patrice Mathevet, Rami Hajri, Jean‐Luc Bulliard, Khalil Zaman, Karen Brändle, Murielle Bochud, R. Freund
article en

Abstract

In Switzerland, breast cancer screening takes the form of organised programmes or opportunistic screening. Current programmes cover fifteen out of twenty-six cantons, offer a standardised framework and strict quality control with periodic evaluations. Opportunistic screening broadens access but without systematic quality control, data or equity of access. In both cases, screening leads to earlier detection and reduced mortality of breast cancer but exposes patients to the risks of false positives and overdiagnosis. Abstaining from screening increases the risk of late diagnosis and heavy treatment. An interprofessional approach involving primary care physicians, specialists and public health actors is essential to inform women and offer them high-quality screening that is better integrated into their care pathway.

Revue Médicale SuisseVol. 21(937)
Centre Hospitalier Universitaire Vaudois (CH), Centre universitaire de médecine générale et santé publique, Lausanne (CH)
Openalex Percentile: Top 58%
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.